IP Library Granted Patent US 8,546,566
Granted Patent B2
US 8,546,566 · App. 13/233,066 · Granted Oct 1, 2013

Process for manufacturing dihydropteridinones and intermediates thereof

Inventors: Juergen Schnaubelt (Oberhoefen/Warthausen, DE); Rolf Herter (Biberach an der Riss, DE)
Assignee: Boehringer Ingelheim International GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,546,566
App. No.
13/233,066
Granted
Oct 1, 2013
Kind
B2
Abstract

The present invention relates to an improved process for manufacturing dihydropteridinones of general formula (12) as well as intermediates thereof, wherein the groups R 1 , R 2 , R 3 , R 4 , and R 5 have the meanings given in the claims and specification.

Claims (84)

1. A process for manufacturing of a compound of formula (5)

wherein

R 5 denotes C 1 -C 6 -alkyl, C 1 -C 4 -alkyl-C 3 -C 10 -cycloalkyl or C 3 -C 10 -cycloalkyl,

comprising

reacting a compound of formula (3)

wherein PG is a protecting group

with a compound of formula (4)

wherein

R 5 is as hereinbefore defined,

via an enamine intermediate which is hydrogenated in the presence of a metal catalyst and a solvent or a mixture of solvents.

2. A process for manufacturing a compound of formula (6)

wherein

R 5 denotes C 1 -C 6 -alkyl, C 1 -C 4 -alkyl-C 3 -C 10 -cycloalkyl or C 3 -C 10 -cycloalkyl,

comprising removing by acidic hydrolysis the protecting group PG in a compound of formula (5)

wherein

R 5 and PG are as hereinbefore defined, to produce the compound of formula (6).

3. A process for manufacturing a compound of formula (8)

wherein

R 5 denotes C 1 -C 6 -alkyl, C 1 -C 4 -alkyl-C 3 -C 10 -cycloalkyl or C 3 -C 10 -cycloalkyl,

R 4 denotes hydrogen or a group selected from among —CN, hydroxy, C 1 -C 6 -alkyl, C 1 -C 5 -alkyloxy and C 1 -C 6 -alkylthio,

comprising

reacting a compound of formula (7)

wherein

R 4 is as hereinbefore defined, and wherein (7) is optionally converted into an acyl halide compound, with the amine compound of formula (6)

wherein

R 5 is as hereinbefore defined,

using an alkali or alkaline earth hydroxide as base, and a protic solvent.

4. A process for manufacturing a compound of formula (9)

wherein

R 4 denotes hydrogen or a group selected from among —CN, hydroxy, C 1 -C 6 -alkyl, C 1 -C 5 -alkyloxy and C 1 -C 6 -alkylthio,

and R 5 denotes C 1 -C 6 -alkyl, C 1 -C 4 -alkyl-C 3 -C 10 -cycloalkyl or C 3 -C 10 -cycloalkyl,

comprising

1) reacting a compound of formula (3)

wherein PG is a protecting group

with a compound of formula (4)

wherein

R 5 is as hereinbefore defined,

via an enamine intermediate which is hydrogenated in the presence of a metal catalyst and a solvent or a mixture of solvents to produce

2) removing by acidic hydrolysis using p-toluenesulfonic acid (TsOH) the protecting group PG in a compound of formula (5) to produce (6)

3) reacting a compound of formula (7)

wherein (7) is optionally converted into an acyl halide compound, with the amine compound of formula (6)

using an alkali or alkaline earth hydroxide as base, and a protic solvent, to obtain

and

4) the compound of formula (8) is hydrogenated to obtain a compound of formula (9).

5. A process for manufacturing a compound of formula (11)

comprising

reacting a compound of formula (9)

with a compound of formula (10)

wherein A is a leaving group,

to obtain a compound of formula (11),

wherein R 1 and R 2 denote independently from each other a hydrogen or C 1 -C 6 -alkyl,

R 3 denotes hydrogen or a group selected from C 1 -C 6 -alkyl and C 3 -C 8 -cycloalkyl,

R 4 denotes hydrogen or a group selected from among —CN, hydroxy, C 1 -C 6 -alkyl, C 1 -C 5 -alkyloxy and C 1 -C 6 -alkylthio,

R 5 denotes C 1 -C 6 -alkyl, C 1 -C 4 -alkyl-C 3 -C 8 -cycloalkyl or C 3 -C 8 -cycloalkyl.

6. A process for manufacturing a compound of formula (11)

wherein

wherein R 1 and R 2 denote independently from each other a hydrogen or C 1 -C 6 -alkyl,

R 3 denotes hydrogen or a group selected from C 1 -C 6 -alkyl and C 3 -C 8 -cycloalkyl,

R 4 denotes hydrogen or a group selected from among —CN, hydroxy, C 1 -C 6 -alkyl, C 1 -C 5 -alkyloxy and C 1 -C 6 -alkylthio,

R 5 denotes C 1 -C 6 -alkyl, C 1 -C 4 -alkyl-C 3 -C 8 -cycloalkyl or C 3 -C 8 -cycloalkyl,

comprising

hydrogenating a compound of formula (8)

to produce

reacting a compound of formula (9)

wherein

with a compound of formula (10)

wherein A is a leaving group,

to obtain a compound of formula (11).

7. A process (step 4) for manufacturing a compound of formula (9)

wherein

R 4 denotes hydrogen or a group selected from among —CN, hydroxy, C 1 -C 6 -alkyl, C 1 -C 5 -alkyloxy and C 1 -C 6 -alkylthio,

R 5 denotes C 1 -C 6 -alkyl, C 1 -C 4 -alkyl-C 3 -C 8 -cycloalkyl or C 3 -C 8 -cycloalkyl,

comprising hydrogenating a compound of formula (8)

8. The process according to claim 1 wherein the metal catalyst is selected from Pt/C or platinum-IV-oxide (PtO 2 ).

9. The process according to claim 1 wherein the solvent is selected from

an aprotic organic solvent selected from dichloromethane, acetone, ethylene glycol dimethyl ether, diglyme, toluene, tetrahydrofuran (THF),

or

an alcohol selected from ethanol, methanol, isopropanol, n-propanol, n-butanol and/or tert.-butanol,

or

a mixture of an aprotic solvent and an alcohol.

10. The process according to claim 9 , wherein the solvent is toluene:alcohol, adjusted in the range of 4-5:1.

11. The process according to claim 4 wherein the compounds produced may be in the form of the tautomers, the racemates, the enantiomers, the diastereomers and the mixtures thereof, and optionally the salts thereof.

12. A process according to claim 1 characterized in that the metal catalyst is selected from the group consisting of a Ni catalyst, Pd catalyst or a Pt catalyst.

13. A process according to claim 12 characterized in that the metal catalyst is Pt/C or platinum-IV-oxide (PtO 2 ).

Assignments (2)
CONFIRMATORY LICENSE Recorded May 21, 2020
From: BOEHRINGER INGELHEIM PHARMA GMBH
To: ONCOHEROES BIOSCIENCES INC.
Reel/Frame 052722/0909 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2011
From: SCHNAUBELT, JUERGEN; HERTER, ROLF
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 027016/0126 →
Priority Claims (1)
EP 10187194 · Oct 12, 2010 · regional
Continuity (1)
Related Publication 20120238754A1 · Sep 20, 2012